873 related articles for article (PubMed ID: 27092773)
41. Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia.
Hattermann K; Sebens S; Helm O; Schmitt AD; Mentlein R; Mehdorn HM; Held-Feindt J
Oncol Rep; 2014 Jul; 32(1):270-6. PubMed ID: 24859792
[TBL] [Abstract][Full Text] [Related]
42. Targeting tumor cell-to-macrophage communication by blocking Vtn-C1qbp interaction inhibits tumor progression via enhancing macrophage phagocytosis.
Zhang C; Liu Y; Jiang J; Chen C; Duan Z; Su H; Wang S; Tian B; Shi Y; Xiang R; Luo Y
Theranostics; 2024; 14(7):2757-2776. PubMed ID: 38773982
[No Abstract] [Full Text] [Related]
43. [Effectiveness of anti-CD47 antibody and Ara-C combination targeting therapy NOD/SCID mouse of myeloid leukemia].
Wang YC; Feng L; Yin CY; Ma LN; Wei YW; Wang CM; Sheng GY
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):577-82. PubMed ID: 23866283
[TBL] [Abstract][Full Text] [Related]
44. Histone deacetylase 9 deficiency exaggerates uterine M2 macrophage polarization.
Liu Y; Du M; Lin HY
J Cell Mol Med; 2021 Aug; 25(16):7690-7708. PubMed ID: 34145738
[TBL] [Abstract][Full Text] [Related]
45. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
[TBL] [Abstract][Full Text] [Related]
46. Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy.
Zhou Y; Guo Y; Chen L; Zhang X; Wu W; Yang Z; Li X; Wang Y; Hu Z; Wang Z
Theranostics; 2022; 12(12):5488-5503. PubMed ID: 35910792
[No Abstract] [Full Text] [Related]
47. Notch Signaling Modulates Macrophage Polarization and Phagocytosis Through Direct Suppression of Signal Regulatory Protein α Expression.
Lin Y; Zhao JL; Zheng QJ; Jiang X; Tian J; Liang SQ; Guo HW; Qin HY; Liang YM; Han H
Front Immunol; 2018; 9():1744. PubMed ID: 30105024
[TBL] [Abstract][Full Text] [Related]
48. Soluble extracellular domains of human SIRPα and CD47 expressed in Escherichia coli enhances the phagocytosis of leukemia cells by macrophages in vitro.
Lin Y; Yan XQ; Yang F; Yang XW; Jiang X; Zhao XC; Zhu BK; Liu L; Qin HY; Liang YM; Han H
Protein Expr Purif; 2012 Sep; 85(1):109-16. PubMed ID: 22813925
[TBL] [Abstract][Full Text] [Related]
49. Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis.
Jones JD; Sinder BP; Paige D; Soki FN; Koh AJ; Thiele S; Shiozawa Y; Hofbauer LC; Daignault S; Roca H; McCauley LK
Neoplasia; 2019 Feb; 21(2):172-184. PubMed ID: 30591422
[TBL] [Abstract][Full Text] [Related]
50. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide.
Genin M; Clement F; Fattaccioli A; Raes M; Michiels C
BMC Cancer; 2015 Aug; 15():577. PubMed ID: 26253167
[TBL] [Abstract][Full Text] [Related]
51. Carboxyl- and amino-functionalized polystyrene nanoparticles differentially affect the polarization profile of M1 and M2 macrophage subsets.
Fuchs AK; Syrovets T; Haas KA; Loos C; Musyanovych A; Mailänder V; Landfester K; Simmet T
Biomaterials; 2016 Apr; 85():78-87. PubMed ID: 26854393
[TBL] [Abstract][Full Text] [Related]
52. M2 polarization enhances silica nanoparticle uptake by macrophages.
Hoppstädter J; Seif M; Dembek A; Cavelius C; Huwer H; Kraegeloh A; Kiemer AK
Front Pharmacol; 2015; 6():55. PubMed ID: 25852557
[TBL] [Abstract][Full Text] [Related]
53. Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages.
Lv Z; Bian Z; Shi L; Niu S; Ha B; Tremblay A; Li L; Zhang X; Paluszynski J; Liu M; Zen K; Liu Y
J Immunol; 2015 Jul; 195(2):661-71. PubMed ID: 26085683
[TBL] [Abstract][Full Text] [Related]
54. Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.
Wu M; Wu L; Wu W; Zhu M; Li J; Wang Z; Li J; Ding R; Liang Y; Li L; Zhang T; Huang B; Cai Y; Li K; Li L; Zhang R; Hu B; Lin F; Wang X; Zheng S; Chen J; You Y; Jiang T; Zhang J; Chen H; Wang Q
Cancer Res; 2023 Mar; 83(5):771-785. PubMed ID: 36622331
[TBL] [Abstract][Full Text] [Related]
55. Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma.
Zhang X; Chen W; Fan J; Wang S; Xian Z; Luan J; Li Y; Wang Y; Nan Y; Luo M; Li S; Tian W; Ju D
Carcinogenesis; 2018 May; 39(5):689-699. PubMed ID: 29538621
[TBL] [Abstract][Full Text] [Related]
56. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.
van den Bossche WBL; Kleijn A; Teunissen CE; Voerman JSA; Teodosio C; Noske DP; van Dongen JJM; Dirven CMF; Lamfers MLM
Neuro Oncol; 2018 Oct; 20(11):1494-1504. PubMed ID: 29796615
[TBL] [Abstract][Full Text] [Related]
57. Enhancing antibody-dependent cellular phagocytosis by Re-education of tumor-associated macrophages with resiquimod-encapsulated liposomes.
Li H; Somiya M; Kuroda S
Biomaterials; 2021 Jan; 268():120601. PubMed ID: 33338932
[TBL] [Abstract][Full Text] [Related]
58. Supermolecular nanovehicles co-delivering TLR7/8-agonist and anti-CD47 siRNA for enhanced tumor immunotherapy.
Shang T; Yu X; Gu Y; Du R; Cai Y; Li Y; Zheng G; Wang C; Zhang J; Liu J; Han S; Yang B
Int J Biol Macromol; 2023 Nov; 251():126539. PubMed ID: 37634787
[TBL] [Abstract][Full Text] [Related]
59. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
[TBL] [Abstract][Full Text] [Related]
60. Proinflammatory polarization strongly reduces human macrophage in vitro phagocytosis of tumor cells in response to CD47 blockade.
Antonsen KW; Jensen AG; Carstensen M; Nejsum LN; Sorensen BS; Etzerodt A; Moestrup SK; Møller HJ
Eur J Immunol; 2024 Apr; ():e2350824. PubMed ID: 38593339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]